NCBI National Center for Biotechnology Information |
6USX: Identification of the Clinical Development Candidate MRTX849, a Covalent KRASG12C Inhibitor for the Treatment of Cancer | |||||||||||||||||||||
* Click molecule labels to explore molecular sequence information.
|